Tag: Cancer
-
Exploring How Arsenic Combats Leukemia
A Northwestern Medicine study unearthed the mechanisms behind arsenic’s anti-cancer effects to show how the chemical compound could combat multiple types of leukemia.
-
Potential Therapy Found for Incurable Pediatric Brain Tumor
Northwestern Medicine scientists have discovered a new potential drug therapy for pediatric brainstem glioma by targeting a genetic mutation found in patients with the rare, incurable cancer.
-
Stopping Tumor Growth During Hypoxia
Inhibiting a ubiquitin ligase stops tumor growth during hypoxia, a common characteristic of lung and brain cancers.
-
Platanias Appointed Director of Lurie Cancer Center
Leonidas Platanias, MD, PhD, has been appointed director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a position he has served in interim since January.
-
A Faster, More Accurate Way to Measure Tumor Growth
Northwestern Medicine scientists have found a new method to measure how patients with breast cancer liver metastasis respond to treatment.
-
New Insights for Therapeutic Intervention in Melanoma
Mary J.C. Hendrix, PhD, revealed a variance in signaling pathways in embryonic stem cells and metastatic melanoma cells that may impact new therapeutic strategies in cancer.
-
New Signaling Pathway in Brain Tumors Identified
Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.
-
Health of Young Adult Cancer Survivors Compared to Peers
Young adult cancer survivors reported poorer physical and emotional health but better social health in a study by Northwestern Medicine scientists.
-
Model Predicts Better Outcomes for Brain Tumors with Gene Mutation
A mathematical model can predict whether a tumor has a gene mutation associated with a favorable prognosis for glioblastoma patients.
-
Target Identified to Inhibit Prostate Cancer Cells
Prostate cancer cells producing too much PIM1 are particularly sensitive to the inhibition of a protein called polo-like kinase (PLK1).
